2025 Speakers
Ms Karin Agerman, CSO, CombiGene
Dr Roy Baynes, Senior Vice President Clinical Research, Eikon Therapeutics
Dr. Niklas Beschorner, Head of Rnd, PROVIREX Genome Editing Therapies GmbH
Dr Jaap Boelens, Chief, Stem Cell Transplantation And Cellular Therapies Pediatrics, Memorial Sloan-Kettering Cancer Center
Fred Chereau, SVP, Strategy and Business Development, Alexion Pharmaceuticals
Vicki Coutinho, Consultant, Geni Consulting
Mr Francesco Dazzi, Professor of Regenerative Medicine, King’s College London Executive & Medical Lead, Cell Therapy, astrazeneca
Mr Victor Dillard, VP, Strategy & Operations, Resolution Therapeutics
Marcus Droege, Senior Advisor, Market Access & Commercial, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs
Ms Victoria English, Co-Founder And Editor, Evernow Publications
Gregory Fiore, Chief Executive Officer, Exacis Biotherapeutics
Katherine Forsey, Chief Research Officer, Charcot Marie Tooth Association
Mr Miguel Forte, CEO, Kiji Tx
Dr Saba Ghassemi, Assistant Professor, University of Pennsylvania
Ms Uta Griesenbach, Professor, Molecular Medicine, National Heart And Lung Institute; President, British Society For Gene And Cell Therapy;, Imperial College London
Mr Nagy Habib, Professor, Imperial College London
Dr Patrick Hanley, Chief and Director, Cellular Therapy Program, Children's National Medical Center
Ms Kathy Ivey, Vice President of Gene Therapy Research, Tenaya Therapeutics
Ron Jortner, Founder & Chief Executive Officer, Aspire Biosciences
Mrs Margareth Jorvid, Head of Regulatory Affairs, Ilya Pharma
Ms Angela Justice, Chief People Officer, Justice Group Advisors
Dr Kilian Kelly, Chief Executive Officer & Managing Director, Cynata Therapeutics Ltd
Dr Sven Kili, Chief Development Officer, CCRM & Principal, CCRM
Bence Kozma, Research Assistant PostDoc, TU Wien
Mathias Kroll, Chief Business Officer, Cynata Therapeutics Ltd
Daniel Lewi, Co-founder & Chief Executive Officer, The Cure & Action for Tay-Sachs (CATS) Foundation
Pauline L'Hénaff, Head of Industry Engagement, Access to Medicine Foundation
Dr Alberto Malerba, Lecturer in Gene Therapy, royal holloway university of london
Julius Mathews, Project Manager & Research Fellow, Fraunhofer Institute for Production Technology IPT
Jo Miller, Director, Cell Therapy Sciences
Dr Anji Miller, Skills Lead, Innovation Hubs for Gene Therapies/Director Translational Skills, LifeArc
Deana Mohr, Chief Executive Officer, MUVON Therapeutics
Paolo Morgese, Vice President, Public Affairs, Europe, Alliance for Regenerative Medicine
Dr David Morrow, manager, EATRIS
Alexander Natz, Director General, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs
Mr Roberto Nitsch, Director, AstraZeneca
Ms Nneka Onwudiwe, Former PRO/PE Regulatory Review Officer, Food and Drug Administration (FDA)
Kinnari Patel, President & COO, Rocket Pharma
Rik Patel, Senior Trade Manager, London & Partners
Dr Tom Payne, Chief Operating Officer, Laverock Therapeutics
Trine Pilgaard, Director, Head of Market Access, Denmark and Iceland, Pfizer
Ms Nicola Redfern, Director, NJ Redfern Ltd.
Mr Sean Russell, Head of Translational Project Management & Regulatory Affairs, Telethon Foundation
Mr Matthias Stöcker, Capability Lead, Boehringer-Ingelheim
Stephen Sullivan, COO, iPSirius
Dr Marina Tarunina, Research Director, Plasticell
Mr Stefanos Theoharis, Chief Executive Officer, OneChain Immunotherapeutics
Dr. Marco Traub Marco Traub, Chief Executive Officer, Tesct—Society
Mr Ben Weil, Director of Manufacturing, INmune Bio
Anna Louisa Weltin, Research Fellow, Fraunhofer IPT
Prof Darius Widera, Professor of Stem Cell Biology and Regenerative Medicine, University of Reading
Mr Chris Williams, Chief Business Officer, Autolus Therapeutics
Get Involved with Advanced Therapies Congress
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events